247 related articles for article (PubMed ID: 2484688)
1. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo.
Gerzer R; Drummer C; Karrenbrock B; Heim JM
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition of platelet aggregation by endothelium-derived relaxing factor-like agents].
Gerzer R; Karrenbrock B; Drummer C; Heim JM
Med Klin (Munich); 1990 Feb; 85 Suppl 1():18-22. PubMed ID: 2185403
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
Gerzer R; Karrenbrock B; Siess W; Heim JM
Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
[TBL] [Abstract][Full Text] [Related]
4. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation.
Bult H; Fret HR; Herman AG
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S120-3. PubMed ID: 2484689
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
Kukovetz WR; Holzmann S
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):260-5. PubMed ID: 3031569
[TBL] [Abstract][Full Text] [Related]
8. [Platelet aggregation with SIN 1: comparison with isosorbide-5-mononitrate and acetylsalicylic acid].
Gerzer R; Karrenbrock B; Niederreiter B; Heim JM; Drummer C
Z Kardiol; 1991; 80 Suppl 5():9-11. PubMed ID: 1776339
[TBL] [Abstract][Full Text] [Related]
9. Effect of molsidomine on ex vivo platelet aggregation and plasma guanosine 3':5'-cyclic monophosphate levels in healthy volunteers.
Karrenbrock B; Heim JM; Gerzer R
Klin Wochenschr; 1990 Feb; 68(4):213-7. PubMed ID: 2156106
[TBL] [Abstract][Full Text] [Related]
10. Direct inhibition of platelet function by organic nitrates via nitric oxide formation.
Weber AA; Strobach H; Schrör K
Eur J Pharmacol; 1993 Sep; 247(1):29-37. PubMed ID: 8258358
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of platelet activation by endothelium-derived relaxing factor EDRF/NO and NO releasing dilator substances].
Bassenge E
Z Kardiol; 1991; 80 Suppl 5():17-21. PubMed ID: 1776330
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
13. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
14. [Isosorbide dinitrate inhibits in vitro platelet aggregation at submicromolar concentrations].
Gachet C; Guillou J; Moog S; Cazenave JP
Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():61-5. PubMed ID: 1326933
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
16. [Molsidomine: importance in treatment of circulation disorders].
Kmieć M; Ochmański W
Przegl Lek; 1998; 55(10):532-6. PubMed ID: 10224868
[TBL] [Abstract][Full Text] [Related]
17. Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo.
Spiecker M; Darius H; Meyer J
Thromb Res; 1993 Jun; 70(5):405-15. PubMed ID: 7690993
[TBL] [Abstract][Full Text] [Related]
18. Molsidomine.
Reden J
Blood Vessels; 1990; 27(2-5):282-94. PubMed ID: 2242448
[TBL] [Abstract][Full Text] [Related]
19. Anti-ischemic actions of molsidomine by venous and large coronary dilatation in combination with antiplatelet effects.
Bassenge E; Mülsch A
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S23-8. PubMed ID: 2484695
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
